Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA) Stock Competitors & Peer Comparison
See MCTA's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Care Facilities Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for MCTA and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| MCTA | $29.36 | +0.00% | 445.6M | 419.36 | $0.07 | N/A |
| HCA | $389.62 | +1.94% | 86.4B | 13.45 | $28.96 | +0.77% |
| THC | $243.36 | +4.36% | 21B | 14.12 | $17.24 | N/A |
| DVA | $236.31 | +0.37% | 15.2B | 20.14 | $11.73 | N/A |
| SOLV | $80.47 | +3.15% | 13.9B | 12.89 | $6.24 | N/A |
| FMS | $24.87 | +1.14% | 13.4B | 9.87 | $2.52 | +3.46% |
| EHC | $113.88 | +0.88% | 11.3B | 20.00 | $5.69 | +0.67% |
| ENSG | $178.07 | +2.94% | 10.4B | 25.81 | $6.90 | +0.14% |
| UHS | $159.31 | +2.29% | 10B | 7.07 | $22.54 | +0.50% |
| OSH | $39.00 | +0.08% | 9.5B | -17.65 | -$2.21 | N/A |
Stock Comparison
HCA Healthcare, Inc. (NYSE: HCA)
MCTA vs HCA Comparison July 2026
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCTA stands at 445.6M. In comparison, HCA has a market cap of 86.4B. Regarding current trading prices, MCTA is priced at $29.36 on the NASDAQ, while HCA trades at $389.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCTA currently has a P/E ratio of 419.36, whereas HCA's P/E ratio is 13.45. In terms of profitability, MCTA's ROE is -2.33%, compared to HCA's ROE of -1.13%. Regarding short-term risk, MCTA is less volatile compared to HCA. This indicates lower risk in terms of short-term price fluctuations for MCTA.Check HCA's competition here
Tenet Healthcare Corporation (NYSE: THC)
MCTA vs THC Comparison July 2026
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCTA stands at 445.6M. In comparison, THC has a market cap of 21B. Regarding current trading prices, MCTA is priced at $29.36 on the NASDAQ, while THC trades at $243.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCTA currently has a P/E ratio of 419.36, whereas THC's P/E ratio is 14.12. In terms of profitability, MCTA's ROE is -2.33%, compared to THC's ROE of +0.51%. Regarding short-term risk, MCTA is less volatile compared to THC. This indicates lower risk in terms of short-term price fluctuations for MCTA.Check THC's competition here
DaVita Inc. (NYSE: DVA)
MCTA vs DVA Comparison July 2026
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCTA stands at 445.6M. In comparison, DVA has a market cap of 15.2B. Regarding current trading prices, MCTA is priced at $29.36 on the NASDAQ, while DVA trades at $236.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCTA currently has a P/E ratio of 419.36, whereas DVA's P/E ratio is 20.14. In terms of profitability, MCTA's ROE is -2.33%, compared to DVA's ROE of -1.33%. Regarding short-term risk, MCTA is less volatile compared to DVA. This indicates lower risk in terms of short-term price fluctuations for MCTA.Check DVA's competition here
Solventum Corporation (NYSE: SOLV)
MCTA vs SOLV Comparison July 2026
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCTA stands at 445.6M. In comparison, SOLV has a market cap of 13.9B. Regarding current trading prices, MCTA is priced at $29.36 on the NASDAQ, while SOLV trades at $80.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCTA currently has a P/E ratio of 419.36, whereas SOLV's P/E ratio is 12.89. In terms of profitability, MCTA's ROE is -2.33%, compared to SOLV's ROE of +0.31%. Regarding short-term risk, MCTA is less volatile compared to SOLV. This indicates lower risk in terms of short-term price fluctuations for MCTA.Check SOLV's competition here
Fresenius Medical Care AG & Co. KGaA (NYSE: FMS)
MCTA vs FMS Comparison July 2026
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCTA stands at 445.6M. In comparison, FMS has a market cap of 13.4B. Regarding current trading prices, MCTA is priced at $29.36 on the NASDAQ, while FMS trades at $24.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCTA currently has a P/E ratio of 419.36, whereas FMS's P/E ratio is 9.87. In terms of profitability, MCTA's ROE is -2.33%, compared to FMS's ROE of +0.07%. Regarding short-term risk, MCTA is less volatile compared to FMS. This indicates lower risk in terms of short-term price fluctuations for MCTA.Check FMS's competition here
Encompass Health Corporation (NYSE: EHC)
MCTA vs EHC Comparison July 2026
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCTA stands at 445.6M. In comparison, EHC has a market cap of 11.3B. Regarding current trading prices, MCTA is priced at $29.36 on the NASDAQ, while EHC trades at $113.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCTA currently has a P/E ratio of 419.36, whereas EHC's P/E ratio is 20.00. In terms of profitability, MCTA's ROE is -2.33%, compared to EHC's ROE of +0.25%. Regarding short-term risk, MCTA is less volatile compared to EHC. This indicates lower risk in terms of short-term price fluctuations for MCTA.Check EHC's competition here
The Ensign Group, Inc. (NASDAQ: ENSG)
MCTA vs ENSG Comparison July 2026
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCTA stands at 445.6M. In comparison, ENSG has a market cap of 10.4B. Regarding current trading prices, MCTA is priced at $29.36 on the NASDAQ, while ENSG trades at $178.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCTA currently has a P/E ratio of 419.36, whereas ENSG's P/E ratio is 25.81. In terms of profitability, MCTA's ROE is -2.33%, compared to ENSG's ROE of +0.17%. Regarding short-term risk, MCTA is less volatile compared to ENSG. This indicates lower risk in terms of short-term price fluctuations for MCTA.Check ENSG's competition here
Universal Health Services, Inc. (NYSE: UHS)
MCTA vs UHS Comparison July 2026
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCTA stands at 445.6M. In comparison, UHS has a market cap of 10B. Regarding current trading prices, MCTA is priced at $29.36 on the NASDAQ, while UHS trades at $159.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCTA currently has a P/E ratio of 419.36, whereas UHS's P/E ratio is 7.07. In terms of profitability, MCTA's ROE is -2.33%, compared to UHS's ROE of +0.21%. Regarding short-term risk, MCTA is less volatile compared to UHS. This indicates lower risk in terms of short-term price fluctuations for MCTA.Check UHS's competition here
Oak Street Health, Inc. (NYSE: OSH)
MCTA vs OSH Comparison July 2026
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCTA stands at 445.6M. In comparison, OSH has a market cap of 9.5B. Regarding current trading prices, MCTA is priced at $29.36 on the NASDAQ, while OSH trades at $39.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCTA currently has a P/E ratio of 419.36, whereas OSH's P/E ratio is -17.65. In terms of profitability, MCTA's ROE is -2.33%, compared to OSH's ROE of +4.64%. Regarding short-term risk, MCTA is less volatile compared to OSH. This indicates lower risk in terms of short-term price fluctuations for MCTA.Check OSH's competition here
PACS Group, Inc. (NYSE: PACS)
MCTA vs PACS Comparison July 2026
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCTA stands at 445.6M. In comparison, PACS has a market cap of 7.4B. Regarding current trading prices, MCTA is priced at $29.36 on the NASDAQ, while PACS trades at $47.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCTA currently has a P/E ratio of 419.36, whereas PACS's P/E ratio is 39.97. In terms of profitability, MCTA's ROE is -2.33%, compared to PACS's ROE of +0.27%. Regarding short-term risk, MCTA is less volatile compared to PACS. This indicates lower risk in terms of short-term price fluctuations for MCTA.Check PACS's competition here
Chemed Corporation (NYSE: CHE)
MCTA vs CHE Comparison July 2026
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCTA stands at 445.6M. In comparison, CHE has a market cap of 6.8B. Regarding current trading prices, MCTA is priced at $29.36 on the NASDAQ, while CHE trades at $509.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCTA currently has a P/E ratio of 419.36, whereas CHE's P/E ratio is 23.56. In terms of profitability, MCTA's ROE is -2.33%, compared to CHE's ROE of +0.25%. Regarding short-term risk, MCTA is less volatile compared to CHE. This indicates lower risk in terms of short-term price fluctuations for MCTA.Check CHE's competition here
LHC Group, Inc. (NASDAQ: LHCG)
MCTA vs LHCG Comparison July 2026
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCTA stands at 445.6M. In comparison, LHCG has a market cap of 5.3B. Regarding current trading prices, MCTA is priced at $29.36 on the NASDAQ, while LHCG trades at $169.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCTA currently has a P/E ratio of 419.36, whereas LHCG's P/E ratio is 82.83. In terms of profitability, MCTA's ROE is -2.33%, compared to LHCG's ROE of +0.04%. Regarding short-term risk, MCTA is less volatile compared to LHCG. This indicates lower risk in terms of short-term price fluctuations for MCTA.Check LHCG's competition here
LifeStance Health Group, Inc. (NASDAQ: LFST)
MCTA vs LFST Comparison July 2026
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCTA stands at 445.6M. In comparison, LFST has a market cap of 4.2B. Regarding current trading prices, MCTA is priced at $29.36 on the NASDAQ, while LFST trades at $10.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCTA currently has a P/E ratio of 419.36, whereas LFST's P/E ratio is 173.33. In terms of profitability, MCTA's ROE is -2.33%, compared to LFST's ROE of +0.02%. Regarding short-term risk, MCTA is less volatile compared to LFST. This indicates lower risk in terms of short-term price fluctuations for MCTA.Check LFST's competition here
Concentra Group Holdings Parent, Inc. (NYSE: CON)
MCTA vs CON Comparison July 2026
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCTA stands at 445.6M. In comparison, CON has a market cap of 4.1B. Regarding current trading prices, MCTA is priced at $29.36 on the NASDAQ, while CON trades at $31.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCTA currently has a P/E ratio of 419.36, whereas CON's P/E ratio is 22.17. In terms of profitability, MCTA's ROE is -2.33%, compared to CON's ROE of +0.46%. Regarding short-term risk, MCTA is less volatile compared to CON. This indicates lower risk in terms of short-term price fluctuations for MCTA.Check CON's competition here
Brookdale Senior Living Inc. (NYSE: BKD)
MCTA vs BKD Comparison July 2026
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCTA stands at 445.6M. In comparison, BKD has a market cap of 3.7B. Regarding current trading prices, MCTA is priced at $29.36 on the NASDAQ, while BKD trades at $15.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCTA currently has a P/E ratio of 419.36, whereas BKD's P/E ratio is -26.66. In terms of profitability, MCTA's ROE is -2.33%, compared to BKD's ROE of +401.19%. Regarding short-term risk, MCTA is less volatile compared to BKD. This indicates lower risk in terms of short-term price fluctuations for MCTA.Check BKD's competition here
National HealthCare Corporation (AMEX: NHC)
MCTA vs NHC Comparison July 2026
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCTA stands at 445.6M. In comparison, NHC has a market cap of 3.5B. Regarding current trading prices, MCTA is priced at $29.36 on the NASDAQ, while NHC trades at $226.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCTA currently has a P/E ratio of 419.36, whereas NHC's P/E ratio is 32.46. In terms of profitability, MCTA's ROE is -2.33%, compared to NHC's ROE of +0.12%. Regarding short-term risk, MCTA is less volatile compared to NHC. This indicates lower risk in terms of short-term price fluctuations for MCTA.Check NHC's competition here
Option Care Health, Inc. (NASDAQ: OPCH)
MCTA vs OPCH Comparison July 2026
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCTA stands at 445.6M. In comparison, OPCH has a market cap of 3.4B. Regarding current trading prices, MCTA is priced at $29.36 on the NASDAQ, while OPCH trades at $21.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCTA currently has a P/E ratio of 419.36, whereas OPCH's P/E ratio is 12.68. In terms of profitability, MCTA's ROE is -2.33%, compared to OPCH's ROE of +0.15%. Regarding short-term risk, MCTA is less volatile compared to OPCH. This indicates lower risk in terms of short-term price fluctuations for MCTA.Check OPCH's competition here
Amedisys, Inc. (NASDAQ: AMED)
MCTA vs AMED Comparison July 2026
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCTA stands at 445.6M. In comparison, AMED has a market cap of 3.3B. Regarding current trading prices, MCTA is priced at $29.36 on the NASDAQ, while AMED trades at $100.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCTA currently has a P/E ratio of 419.36, whereas AMED's P/E ratio is 39.30. In terms of profitability, MCTA's ROE is -2.33%, compared to AMED's ROE of +0.11%. Regarding short-term risk, MCTA is less volatile compared to AMED. This indicates lower risk in terms of short-term price fluctuations for MCTA.Check AMED's competition here
Acadia Healthcare Company, Inc. (NASDAQ: ACHC)
MCTA vs ACHC Comparison July 2026
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCTA stands at 445.6M. In comparison, ACHC has a market cap of 3B. Regarding current trading prices, MCTA is priced at $29.36 on the NASDAQ, while ACHC trades at $32.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCTA currently has a P/E ratio of 419.36, whereas ACHC's P/E ratio is 16.33. In terms of profitability, MCTA's ROE is -2.33%, compared to ACHC's ROE of -0.44%. Regarding short-term risk, MCTA is less volatile compared to ACHC. This indicates lower risk in terms of short-term price fluctuations for MCTA.Check ACHC's competition here
Addus HomeCare Corporation (NASDAQ: ADUS)
MCTA vs ADUS Comparison July 2026
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCTA stands at 445.6M. In comparison, ADUS has a market cap of 2.2B. Regarding current trading prices, MCTA is priced at $29.36 on the NASDAQ, while ADUS trades at $115.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCTA currently has a P/E ratio of 419.36, whereas ADUS's P/E ratio is 17.96. In terms of profitability, MCTA's ROE is -2.33%, compared to ADUS's ROE of +0.09%. Regarding short-term risk, MCTA is less volatile compared to ADUS. This indicates lower risk in terms of short-term price fluctuations for MCTA.Check ADUS's competition here
Pediatrix Medical Group, Inc. (NYSE: MD)
MCTA vs MD Comparison July 2026
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCTA stands at 445.6M. In comparison, MD has a market cap of 2.1B. Regarding current trading prices, MCTA is priced at $29.36 on the NASDAQ, while MD trades at $26.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCTA currently has a P/E ratio of 419.36, whereas MD's P/E ratio is 12.21. In terms of profitability, MCTA's ROE is -2.33%, compared to MD's ROE of +0.20%. Regarding short-term risk, MCTA is less volatile compared to MD. This indicates lower risk in terms of short-term price fluctuations for MCTA.Check MD's competition here
Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH)
MCTA vs AVAH Comparison July 2026
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCTA stands at 445.6M. In comparison, AVAH has a market cap of 2.1B. Regarding current trading prices, MCTA is priced at $29.36 on the NASDAQ, while AVAH trades at $9.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCTA currently has a P/E ratio of 419.36, whereas AVAH's P/E ratio is 14.22. In terms of profitability, MCTA's ROE is -2.33%, compared to AVAH's ROE of +2.41%. Regarding short-term risk, MCTA is less volatile compared to AVAH. This indicates lower risk in terms of short-term price fluctuations for MCTA.Check AVAH's competition here
Select Medical Holdings Corporation (NYSE: SEM)
MCTA vs SEM Comparison July 2026
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCTA stands at 445.6M. In comparison, SEM has a market cap of 2B. Regarding current trading prices, MCTA is priced at $29.36 on the NASDAQ, while SEM trades at $16.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCTA currently has a P/E ratio of 419.36, whereas SEM's P/E ratio is 15.43. In terms of profitability, MCTA's ROE is -2.33%, compared to SEM's ROE of +0.08%. Regarding short-term risk, MCTA is less volatile compared to SEM. This indicates lower risk in terms of short-term price fluctuations for MCTA.Check SEM's competition here
Surgery Partners, Inc. (NASDAQ: SGRY)
MCTA vs SGRY Comparison July 2026
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCTA stands at 445.6M. In comparison, SGRY has a market cap of 2B. Regarding current trading prices, MCTA is priced at $29.36 on the NASDAQ, while SGRY trades at $15.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCTA currently has a P/E ratio of 419.36, whereas SGRY's P/E ratio is 38.90. In terms of profitability, MCTA's ROE is -2.33%, compared to SGRY's ROE of -0.04%. Regarding short-term risk, MCTA is less volatile compared to SGRY. This indicates lower risk in terms of short-term price fluctuations for MCTA.Check SGRY's competition here
Astrana Health, Inc. (NASDAQ: ASTH)
MCTA vs ASTH Comparison July 2026
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCTA stands at 445.6M. In comparison, ASTH has a market cap of 1.9B. Regarding current trading prices, MCTA is priced at $29.36 on the NASDAQ, while ASTH trades at $38.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCTA currently has a P/E ratio of 419.36, whereas ASTH's P/E ratio is 25.80. In terms of profitability, MCTA's ROE is -2.33%, compared to ASTH's ROE of +0.04%. Regarding short-term risk, MCTA is less volatile compared to ASTH. This indicates lower risk in terms of short-term price fluctuations for MCTA.Check ASTH's competition here
Apollo Medical Holdings, Inc. (NASDAQ: AMEH)
MCTA vs AMEH Comparison July 2026
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCTA stands at 445.6M. In comparison, AMEH has a market cap of 1.8B. Regarding current trading prices, MCTA is priced at $29.36 on the NASDAQ, while AMEH trades at $40.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCTA currently has a P/E ratio of 419.36, whereas AMEH's P/E ratio is 39.25. In terms of profitability, MCTA's ROE is -2.33%, compared to AMEH's ROE of +0.04%. Regarding short-term risk, MCTA is less volatile compared to AMEH. This indicates lower risk in terms of short-term price fluctuations for MCTA.Check AMEH's competition here
Agilon Health, Inc. (NYSE: AGL)
MCTA vs AGL Comparison July 2026
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCTA stands at 445.6M. In comparison, AGL has a market cap of 1.6B. Regarding current trading prices, MCTA is priced at $29.36 on the NASDAQ, while AGL trades at $98.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCTA currently has a P/E ratio of 419.36, whereas AGL's P/E ratio is -9.63. In terms of profitability, MCTA's ROE is -2.33%, compared to AGL's ROE of -1.46%. Regarding short-term risk, MCTA is less volatile compared to AGL. This indicates lower risk in terms of short-term price fluctuations for MCTA.Check AGL's competition here
Healthcare Services Group, Inc. (NASDAQ: HCSG)
MCTA vs HCSG Comparison July 2026
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCTA stands at 445.6M. In comparison, HCSG has a market cap of 1.6B. Regarding current trading prices, MCTA is priced at $29.36 on the NASDAQ, while HCSG trades at $22.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCTA currently has a P/E ratio of 419.36, whereas HCSG's P/E ratio is 18.36. In terms of profitability, MCTA's ROE is -2.33%, compared to HCSG's ROE of +0.24%. Regarding short-term risk, MCTA is less volatile compared to HCSG. This indicates lower risk in terms of short-term price fluctuations for MCTA.Check HCSG's competition here
Ardent Health Inc. (NYSE: ARDT)
MCTA vs ARDT Comparison July 2026
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCTA stands at 445.6M. In comparison, ARDT has a market cap of 1.6B. Regarding current trading prices, MCTA is priced at $29.36 on the NASDAQ, while ARDT trades at $10.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCTA currently has a P/E ratio of 419.36, whereas ARDT's P/E ratio is 6.68. In terms of profitability, MCTA's ROE is -2.33%, compared to ARDT's ROE of +0.09%. Regarding short-term risk, MCTA is less volatile compared to ARDT. This indicates lower risk in terms of short-term price fluctuations for MCTA.Check ARDT's competition here
Innovage Holding Corp. (NASDAQ: INNV)
MCTA vs INNV Comparison July 2026
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCTA stands at 445.6M. In comparison, INNV has a market cap of 1.6B. Regarding current trading prices, MCTA is priced at $29.36 on the NASDAQ, while INNV trades at $11.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCTA currently has a P/E ratio of 419.36, whereas INNV's P/E ratio is -127.56. In terms of profitability, MCTA's ROE is -2.33%, compared to INNV's ROE of -0.09%. Regarding short-term risk, MCTA is less volatile compared to INNV. This indicates lower risk in terms of short-term price fluctuations for MCTA.Check INNV's competition here
COMPASS Pathways plc (NASDAQ: CMPS)
MCTA vs CMPS Comparison July 2026
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCTA stands at 445.6M. In comparison, CMPS has a market cap of 1.5B. Regarding current trading prices, MCTA is priced at $29.36 on the NASDAQ, while CMPS trades at $11.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCTA currently has a P/E ratio of 419.36, whereas CMPS's P/E ratio is -5.50. In terms of profitability, MCTA's ROE is -2.33%, compared to CMPS's ROE of -1.51%. Regarding short-term risk, MCTA is less volatile compared to CMPS. This indicates lower risk in terms of short-term price fluctuations for MCTA.Check CMPS's competition here
The Pennant Group, Inc. (NASDAQ: PNTG)
MCTA vs PNTG Comparison July 2026
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCTA stands at 445.6M. In comparison, PNTG has a market cap of 1.4B. Regarding current trading prices, MCTA is priced at $29.36 on the NASDAQ, while PNTG trades at $41.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCTA currently has a P/E ratio of 419.36, whereas PNTG's P/E ratio is 33.61. In terms of profitability, MCTA's ROE is -2.33%, compared to PNTG's ROE of +0.09%. Regarding short-term risk, MCTA is less volatile compared to PNTG. This indicates lower risk in terms of short-term price fluctuations for MCTA.Check PNTG's competition here
AMN Healthcare Services, Inc. (NYSE: AMN)
MCTA vs AMN Comparison July 2026
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCTA stands at 445.6M. In comparison, AMN has a market cap of 1.3B. Regarding current trading prices, MCTA is priced at $29.36 on the NASDAQ, while AMN trades at $33.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCTA currently has a P/E ratio of 419.36, whereas AMN's P/E ratio is 11.11. In terms of profitability, MCTA's ROE is -2.33%, compared to AMN's ROE of -0.05%. Regarding short-term risk, MCTA is less volatile compared to AMN. This indicates lower risk in terms of short-term price fluctuations for MCTA.Check AMN's competition here
Brookdale Senior Living Inc. 7. (NYSE: BKDT)
MCTA vs BKDT Comparison July 2026
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCTA stands at 445.6M. In comparison, BKDT has a market cap of 1.2B. Regarding current trading prices, MCTA is priced at $29.36 on the NASDAQ, while BKDT trades at $77.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCTA currently has a P/E ratio of 419.36, whereas BKDT's P/E ratio is N/A. In terms of profitability, MCTA's ROE is -2.33%, compared to BKDT's ROE of +401.19%. Regarding short-term risk, MCTA is similarly volatile compared to BKDT. This indicates similar risk in terms of short-term price fluctuations for MCTA.Check BKDT's competition here
U.S. Physical Therapy, Inc. (NYSE: USPH)
MCTA vs USPH Comparison July 2026
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCTA stands at 445.6M. In comparison, USPH has a market cap of 1.2B. Regarding current trading prices, MCTA is priced at $29.36 on the NASDAQ, while USPH trades at $76.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCTA currently has a P/E ratio of 419.36, whereas USPH's P/E ratio is 29.48. In terms of profitability, MCTA's ROE is -2.33%, compared to USPH's ROE of +0.00%. Regarding short-term risk, MCTA is less volatile compared to USPH. This indicates lower risk in terms of short-term price fluctuations for MCTA.Check USPH's competition here
Nutex Health, Inc. (NASDAQ: NUTX)
MCTA vs NUTX Comparison July 2026
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCTA stands at 445.6M. In comparison, NUTX has a market cap of 1B. Regarding current trading prices, MCTA is priced at $29.36 on the NASDAQ, while NUTX trades at $148.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCTA currently has a P/E ratio of 419.36, whereas NUTX's P/E ratio is 11.49. In terms of profitability, MCTA's ROE is -2.33%, compared to NUTX's ROE of +0.31%. Regarding short-term risk, MCTA is less volatile compared to NUTX. This indicates lower risk in terms of short-term price fluctuations for MCTA.Check NUTX's competition here
Fidelity Select Health Care Svcs Port (NASDAQ: FSHCX)
MCTA vs FSHCX Comparison July 2026
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCTA stands at 445.6M. In comparison, FSHCX has a market cap of 891.2M. Regarding current trading prices, MCTA is priced at $29.36 on the NASDAQ, while FSHCX trades at $120.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCTA currently has a P/E ratio of 419.36, whereas FSHCX's P/E ratio is N/A. In terms of profitability, MCTA's ROE is -2.33%, compared to FSHCX's ROE of N/A. Regarding short-term risk, MCTA is similarly volatile compared to FSHCX. This indicates similar risk in terms of short-term price fluctuations for MCTA.Check FSHCX's competition here
Talkspace, Inc. (NASDAQ: TALK)
MCTA vs TALK Comparison July 2026
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCTA stands at 445.6M. In comparison, TALK has a market cap of 874.4M. Regarding current trading prices, MCTA is priced at $29.36 on the NASDAQ, while TALK trades at $5.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCTA currently has a P/E ratio of 419.36, whereas TALK's P/E ratio is 769.91. In terms of profitability, MCTA's ROE is -2.33%, compared to TALK's ROE of +0.01%. Regarding short-term risk, MCTA is less volatile compared to TALK. This indicates lower risk in terms of short-term price fluctuations for MCTA.Check TALK's competition here
Sonida Senior Living, Inc. (NYSE: SNDA)
MCTA vs SNDA Comparison July 2026
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCTA stands at 445.6M. In comparison, SNDA has a market cap of 857.2M. Regarding current trading prices, MCTA is priced at $29.36 on the NASDAQ, while SNDA trades at $42.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCTA currently has a P/E ratio of 419.36, whereas SNDA's P/E ratio is -7.94. In terms of profitability, MCTA's ROE is -2.33%, compared to SNDA's ROE of -0.35%. Regarding short-term risk, MCTA is less volatile compared to SNDA. This indicates lower risk in terms of short-term price fluctuations for MCTA.Check SNDA's competition here
Enhabit, Inc. (NYSE: EHAB)
MCTA vs EHAB Comparison July 2026
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCTA stands at 445.6M. In comparison, EHAB has a market cap of 706.9M. Regarding current trading prices, MCTA is priced at $29.36 on the NASDAQ, while EHAB trades at $13.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCTA currently has a P/E ratio of 419.36, whereas EHAB's P/E ratio is -197.14. In terms of profitability, MCTA's ROE is -2.33%, compared to EHAB's ROE of -0.01%. Regarding short-term risk, MCTA is less volatile compared to EHAB. This indicates lower risk in terms of short-term price fluctuations for MCTA.Check EHAB's competition here
GMR Solutions Inc. (NYSE: GMRS)
MCTA vs GMRS Comparison July 2026
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCTA stands at 445.6M. In comparison, GMRS has a market cap of 582.5M. Regarding current trading prices, MCTA is priced at $29.36 on the NASDAQ, while GMRS trades at $12.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCTA currently has a P/E ratio of 419.36, whereas GMRS's P/E ratio is 5.65. In terms of profitability, MCTA's ROE is -2.33%, compared to GMRS's ROE of +1.01%. Regarding short-term risk, MCTA is less volatile compared to GMRS. This indicates lower risk in terms of short-term price fluctuations for MCTA.Check GMRS's competition here
The Oncology Institute, Inc. (NASDAQ: TOI)
MCTA vs TOI Comparison July 2026
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCTA stands at 445.6M. In comparison, TOI has a market cap of 518.9M. Regarding current trading prices, MCTA is priced at $29.36 on the NASDAQ, while TOI trades at $5.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCTA currently has a P/E ratio of 419.36, whereas TOI's P/E ratio is -14.42. In terms of profitability, MCTA's ROE is -2.33%, compared to TOI's ROE of +3.27%. Regarding short-term risk, MCTA is less volatile compared to TOI. This indicates lower risk in terms of short-term price fluctuations for MCTA.Check TOI's competition here
Viemed Healthcare, Inc. (NASDAQ: VMD)
MCTA vs VMD Comparison July 2026
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCTA stands at 445.6M. In comparison, VMD has a market cap of 464.6M. Regarding current trading prices, MCTA is priced at $29.36 on the NASDAQ, while VMD trades at $12.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCTA currently has a P/E ratio of 419.36, whereas VMD's P/E ratio is 32.76. In terms of profitability, MCTA's ROE is -2.33%, compared to VMD's ROE of +0.11%. Regarding short-term risk, MCTA is less volatile compared to VMD. This indicates lower risk in terms of short-term price fluctuations for MCTA.Check VMD's competition here
Strata Critical Medical, Inc. (NASDAQ: SRTA)
MCTA vs SRTA Comparison July 2026
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCTA stands at 445.6M. In comparison, SRTA has a market cap of 444.7M. Regarding current trading prices, MCTA is priced at $29.36 on the NASDAQ, while SRTA trades at $5.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCTA currently has a P/E ratio of 419.36, whereas SRTA's P/E ratio is -36.16. In terms of profitability, MCTA's ROE is -2.33%, compared to SRTA's ROE of +0.18%. Regarding short-term risk, MCTA is less volatile compared to SRTA. This indicates lower risk in terms of short-term price fluctuations for MCTA.Check SRTA's competition here
The Oncology Institute, Inc. (NASDAQ: TOIIW)
MCTA vs TOIIW Comparison July 2026
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCTA stands at 445.6M. In comparison, TOIIW has a market cap of 388.9M. Regarding current trading prices, MCTA is priced at $29.36 on the NASDAQ, while TOIIW trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCTA currently has a P/E ratio of 419.36, whereas TOIIW's P/E ratio is -0.18. In terms of profitability, MCTA's ROE is -2.33%, compared to TOIIW's ROE of +3.27%. Regarding short-term risk, MCTA is less volatile compared to TOIIW. This indicates lower risk in terms of short-term price fluctuations for MCTA.Check TOIIW's competition here
Community Health Systems, Inc. (NYSE: CYH)
MCTA vs CYH Comparison July 2026
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCTA stands at 445.6M. In comparison, CYH has a market cap of 384M. Regarding current trading prices, MCTA is priced at $29.36 on the NASDAQ, while CYH trades at $2.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCTA currently has a P/E ratio of 419.36, whereas CYH's P/E ratio is 3.73. In terms of profitability, MCTA's ROE is -2.33%, compared to CYH's ROE of +0.21%. Regarding short-term risk, MCTA is less volatile compared to CYH. This indicates lower risk in terms of short-term price fluctuations for MCTA.Check CYH's competition here
Auna S.A. (NYSE: AUNA)
MCTA vs AUNA Comparison July 2026
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCTA stands at 445.6M. In comparison, AUNA has a market cap of 378.3M. Regarding current trading prices, MCTA is priced at $29.36 on the NASDAQ, while AUNA trades at $5.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCTA currently has a P/E ratio of 419.36, whereas AUNA's P/E ratio is 4.60. In terms of profitability, MCTA's ROE is -2.33%, compared to AUNA's ROE of +0.04%. Regarding short-term risk, MCTA is less volatile compared to AUNA. This indicates lower risk in terms of short-term price fluctuations for MCTA.Check AUNA's competition here
AirSculpt Technologies, Inc. (NASDAQ: AIRS)
MCTA vs AIRS Comparison July 2026
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCTA stands at 445.6M. In comparison, AIRS has a market cap of 330.9M. Regarding current trading prices, MCTA is priced at $29.36 on the NASDAQ, while AIRS trades at $4.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCTA currently has a P/E ratio of 419.36, whereas AIRS's P/E ratio is -156.33. In terms of profitability, MCTA's ROE is -2.33%, compared to AIRS's ROE of -0.12%. Regarding short-term risk, MCTA is less volatile compared to AIRS. This indicates lower risk in terms of short-term price fluctuations for MCTA.Check AIRS's competition here
Capital Senior Living Corporation (NYSE: CSU)
MCTA vs CSU Comparison July 2026
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCTA stands at 445.6M. In comparison, CSU has a market cap of 223.7M. Regarding current trading prices, MCTA is priced at $29.36 on the NASDAQ, while CSU trades at $33.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCTA currently has a P/E ratio of 419.36, whereas CSU's P/E ratio is 0.67. In terms of profitability, MCTA's ROE is -2.33%, compared to CSU's ROE of -0.51%. Regarding short-term risk, MCTA is less volatile compared to CSU. This indicates lower risk in terms of short-term price fluctuations for MCTA.Check CSU's competition here
The Joint Corp. (NASDAQ: JYNT)
MCTA vs JYNT Comparison July 2026
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCTA stands at 445.6M. In comparison, JYNT has a market cap of 122.2M. Regarding current trading prices, MCTA is priced at $29.36 on the NASDAQ, while JYNT trades at $8.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCTA currently has a P/E ratio of 419.36, whereas JYNT's P/E ratio is 85.70. In terms of profitability, MCTA's ROE is -2.33%, compared to JYNT's ROE of +0.17%. Regarding short-term risk, MCTA is less volatile compared to JYNT. This indicates lower risk in terms of short-term price fluctuations for MCTA.Check JYNT's competition here
biote Corp. (NASDAQ: BTMD)
MCTA vs BTMD Comparison July 2026
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCTA stands at 445.6M. In comparison, BTMD has a market cap of 102.8M. Regarding current trading prices, MCTA is priced at $29.36 on the NASDAQ, while BTMD trades at $2.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCTA currently has a P/E ratio of 419.36, whereas BTMD's P/E ratio is 5.30. In terms of profitability, MCTA's ROE is -2.33%, compared to BTMD's ROE of -0.23%. Regarding short-term risk, MCTA is less volatile compared to BTMD. This indicates lower risk in terms of short-term price fluctuations for MCTA.Check BTMD's competition here
Five Star Senior Living Inc. (NASDAQ: FVE)
MCTA vs FVE Comparison July 2026
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCTA stands at 445.6M. In comparison, FVE has a market cap of 98.4M. Regarding current trading prices, MCTA is priced at $29.36 on the NASDAQ, while FVE trades at $2.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCTA currently has a P/E ratio of 419.36, whereas FVE's P/E ratio is -5.64. In terms of profitability, MCTA's ROE is -2.33%, compared to FVE's ROE of -0.15%. Regarding short-term risk, MCTA is less volatile compared to FVE. This indicates lower risk in terms of short-term price fluctuations for MCTA.Check FVE's competition here
Kindly MD, Inc. (NASDAQ: KDLYW)
MCTA vs KDLYW Comparison July 2026
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCTA stands at 445.6M. In comparison, KDLYW has a market cap of 96.5M. Regarding current trading prices, MCTA is priced at $29.36 on the NASDAQ, while KDLYW trades at $18.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCTA currently has a P/E ratio of 419.36, whereas KDLYW's P/E ratio is N/A. In terms of profitability, MCTA's ROE is -2.33%, compared to KDLYW's ROE of -0.85%. Regarding short-term risk, MCTA is less volatile compared to KDLYW. This indicates lower risk in terms of short-term price fluctuations for MCTA.Check KDLYW's competition here
DocGo Inc. (NASDAQ: DCGO)
MCTA vs DCGO Comparison July 2026
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCTA stands at 445.6M. In comparison, DCGO has a market cap of 62.2M. Regarding current trading prices, MCTA is priced at $29.36 on the NASDAQ, while DCGO trades at $0.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCTA currently has a P/E ratio of 419.36, whereas DCGO's P/E ratio is -0.72. In terms of profitability, MCTA's ROE is -2.33%, compared to DCGO's ROE of -0.89%. Regarding short-term risk, MCTA is less volatile compared to DCGO. This indicates lower risk in terms of short-term price fluctuations for MCTA.Check DCGO's competition here
AlerisLife Inc. (NASDAQ: ALR)
MCTA vs ALR Comparison July 2026
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCTA stands at 445.6M. In comparison, ALR has a market cap of 44.2M. Regarding current trading prices, MCTA is priced at $29.36 on the NASDAQ, while ALR trades at $1.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCTA currently has a P/E ratio of 419.36, whereas ALR's P/E ratio is -1.11. In terms of profitability, MCTA's ROE is -2.33%, compared to ALR's ROE of -0.15%. Regarding short-term risk, MCTA is less volatile compared to ALR. This indicates lower risk in terms of short-term price fluctuations for MCTA.Check ALR's competition here
Park Dental Partners, Inc. Common Stock (NASDAQ: PARK)
MCTA vs PARK Comparison July 2026
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCTA stands at 445.6M. In comparison, PARK has a market cap of 38.4M. Regarding current trading prices, MCTA is priced at $29.36 on the NASDAQ, while PARK trades at $19.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCTA currently has a P/E ratio of 419.36, whereas PARK's P/E ratio is 26.66. In terms of profitability, MCTA's ROE is -2.33%, compared to PARK's ROE of -0.24%. Regarding short-term risk, MCTA is less volatile compared to PARK. This indicates lower risk in terms of short-term price fluctuations for MCTA.Check PARK's competition here
P3 Health Partners Inc. (NASDAQ: PIII)
MCTA vs PIII Comparison July 2026
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCTA stands at 445.6M. In comparison, PIII has a market cap of 34.3M. Regarding current trading prices, MCTA is priced at $29.36 on the NASDAQ, while PIII trades at $10.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCTA currently has a P/E ratio of 419.36, whereas PIII's P/E ratio is -0.26. In terms of profitability, MCTA's ROE is -2.33%, compared to PIII's ROE of +1.85%. Regarding short-term risk, MCTA is less volatile compared to PIII. This indicates lower risk in terms of short-term price fluctuations for MCTA.Check PIII's competition here
IMAC Holdings, Inc. (NASDAQ: IMAC)
MCTA vs IMAC Comparison July 2026
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCTA stands at 445.6M. In comparison, IMAC has a market cap of 33.1M. Regarding current trading prices, MCTA is priced at $29.36 on the NASDAQ, while IMAC trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCTA currently has a P/E ratio of 419.36, whereas IMAC's P/E ratio is -2.27. In terms of profitability, MCTA's ROE is -2.33%, compared to IMAC's ROE of +0.00%. Regarding short-term risk, MCTA is less volatile compared to IMAC. This indicates lower risk in terms of short-term price fluctuations for MCTA.Check IMAC's competition here
Cryo-Cell International, Inc. (AMEX: CCEL)
MCTA vs CCEL Comparison July 2026
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCTA stands at 445.6M. In comparison, CCEL has a market cap of 27.4M. Regarding current trading prices, MCTA is priced at $29.36 on the NASDAQ, while CCEL trades at $3.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCTA currently has a P/E ratio of 419.36, whereas CCEL's P/E ratio is -10.30. In terms of profitability, MCTA's ROE is -2.33%, compared to CCEL's ROE of +0.14%. Regarding short-term risk, MCTA is less volatile compared to CCEL. This indicates lower risk in terms of short-term price fluctuations for MCTA.Check CCEL's competition here
Cano Health, Inc. (NYSE: CANO-WT)
MCTA vs CANO-WT Comparison July 2026
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCTA stands at 445.6M. In comparison, CANO-WT has a market cap of 19.3M. Regarding current trading prices, MCTA is priced at $29.36 on the NASDAQ, while CANO-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCTA currently has a P/E ratio of 419.36, whereas CANO-WT's P/E ratio is N/A. In terms of profitability, MCTA's ROE is -2.33%, compared to CANO-WT's ROE of -1.49%. Regarding short-term risk, MCTA is less volatile compared to CANO-WT. This indicates lower risk in terms of short-term price fluctuations for MCTA.Check CANO-WT's competition here
Aesthetic Medical International Holdings Group Limited (NASDAQ: AIH)
MCTA vs AIH Comparison July 2026
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCTA stands at 445.6M. In comparison, AIH has a market cap of 15.9M. Regarding current trading prices, MCTA is priced at $29.36 on the NASDAQ, while AIH trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCTA currently has a P/E ratio of 419.36, whereas AIH's P/E ratio is -2.78. In terms of profitability, MCTA's ROE is -2.33%, compared to AIH's ROE of +1.16%. Regarding short-term risk, MCTA is less volatile compared to AIH. This indicates lower risk in terms of short-term price fluctuations for MCTA.Check AIH's competition here
Cano Health, Inc. (NYSE: CANO)
MCTA vs CANO Comparison July 2026
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCTA stands at 445.6M. In comparison, CANO has a market cap of 12.4M. Regarding current trading prices, MCTA is priced at $29.36 on the NASDAQ, while CANO trades at $2.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCTA currently has a P/E ratio of 419.36, whereas CANO's P/E ratio is -0.01. In terms of profitability, MCTA's ROE is -2.33%, compared to CANO's ROE of -1.49%. Regarding short-term risk, MCTA is less volatile compared to CANO. This indicates lower risk in terms of short-term price fluctuations for MCTA.Check CANO's competition here
Avem Health Partners, Inc. (NYSE: FPCG)
MCTA vs FPCG Comparison July 2026
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCTA stands at 445.6M. In comparison, FPCG has a market cap of 10.1M. Regarding current trading prices, MCTA is priced at $29.36 on the NASDAQ, while FPCG trades at $1,025.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCTA currently has a P/E ratio of 419.36, whereas FPCG's P/E ratio is 0.09. In terms of profitability, MCTA's ROE is -2.33%, compared to FPCG's ROE of +0.00%. Regarding short-term risk, MCTA is similarly volatile compared to FPCG. This indicates similar risk in terms of short-term price fluctuations for MCTA.Check FPCG's competition here
American Shared Hospital Services (AMEX: AMS)
MCTA vs AMS Comparison July 2026
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCTA stands at 445.6M. In comparison, AMS has a market cap of 10M. Regarding current trading prices, MCTA is priced at $29.36 on the NASDAQ, while AMS trades at $1.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCTA currently has a P/E ratio of 419.36, whereas AMS's P/E ratio is -6.78. In terms of profitability, MCTA's ROE is -2.33%, compared to AMS's ROE of -0.06%. Regarding short-term risk, MCTA is less volatile compared to AMS. This indicates lower risk in terms of short-term price fluctuations for MCTA.Check AMS's competition here
Field Trip Health Ltd. (NASDAQ: FTRP)
MCTA vs FTRP Comparison July 2026
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCTA stands at 445.6M. In comparison, FTRP has a market cap of 9.8M. Regarding current trading prices, MCTA is priced at $29.36 on the NASDAQ, while FTRP trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCTA currently has a P/E ratio of 419.36, whereas FTRP's P/E ratio is -1.22. In terms of profitability, MCTA's ROE is -2.33%, compared to FTRP's ROE of -0.62%. Regarding short-term risk, MCTA is less volatile compared to FTRP. This indicates lower risk in terms of short-term price fluctuations for MCTA.Check FTRP's competition here
Basel Medical Group Ltd Ordinary Shares (NASDAQ: BMGL)
MCTA vs BMGL Comparison July 2026
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCTA stands at 445.6M. In comparison, BMGL has a market cap of 9.2M. Regarding current trading prices, MCTA is priced at $29.36 on the NASDAQ, while BMGL trades at $5.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCTA currently has a P/E ratio of 419.36, whereas BMGL's P/E ratio is -1.11. In terms of profitability, MCTA's ROE is -2.33%, compared to BMGL's ROE of -1.74%. Regarding short-term risk, MCTA is less volatile compared to BMGL. This indicates lower risk in terms of short-term price fluctuations for MCTA.Check BMGL's competition here
XWELL, Inc. (NASDAQ: XWEL)
MCTA vs XWEL Comparison July 2026
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCTA stands at 445.6M. In comparison, XWEL has a market cap of 6.5M. Regarding current trading prices, MCTA is priced at $29.36 on the NASDAQ, while XWEL trades at $1.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCTA currently has a P/E ratio of 419.36, whereas XWEL's P/E ratio is -0.32. In terms of profitability, MCTA's ROE is -2.33%, compared to XWEL's ROE of +2.89%. Regarding short-term risk, MCTA is less volatile compared to XWEL. This indicates lower risk in terms of short-term price fluctuations for MCTA.Check XWEL's competition here
ModivCare Inc. (NASDAQ: MODV)
MCTA vs MODV Comparison July 2026
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCTA stands at 445.6M. In comparison, MODV has a market cap of 6.2M. Regarding current trading prices, MCTA is priced at $29.36 on the NASDAQ, while MODV trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCTA currently has a P/E ratio of 419.36, whereas MODV's P/E ratio is -0.06. In terms of profitability, MCTA's ROE is -2.33%, compared to MODV's ROE of +1.36%. Regarding short-term risk, MCTA is similarly volatile compared to MODV. This indicates similar risk in terms of short-term price fluctuations for MCTA.Check MODV's competition here
Greenbrook TMS Inc. (NASDAQ: GBNH)
MCTA vs GBNH Comparison July 2026
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCTA stands at 445.6M. In comparison, GBNH has a market cap of 5.5M. Regarding current trading prices, MCTA is priced at $29.36 on the NASDAQ, while GBNH trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCTA currently has a P/E ratio of 419.36, whereas GBNH's P/E ratio is -0.06. In terms of profitability, MCTA's ROE is -2.33%, compared to GBNH's ROE of +15.74%. Regarding short-term risk, MCTA is less volatile compared to GBNH. This indicates lower risk in terms of short-term price fluctuations for MCTA.Check GBNH's competition here
Regional Health Properties, Inc. (AMEX: RHE)
MCTA vs RHE Comparison July 2026
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCTA stands at 445.6M. In comparison, RHE has a market cap of 5.2M. Regarding current trading prices, MCTA is priced at $29.36 on the NASDAQ, while RHE trades at $2.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCTA currently has a P/E ratio of 419.36, whereas RHE's P/E ratio is -1.79. In terms of profitability, MCTA's ROE is -2.33%, compared to RHE's ROE of -0.36%. Regarding short-term risk, MCTA is less volatile compared to RHE. This indicates lower risk in terms of short-term price fluctuations for MCTA.Check RHE's competition here
Regional Health Properties, Inc. (AMEX: RHE-PA)
MCTA vs RHE-PA Comparison July 2026
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCTA stands at 445.6M. In comparison, RHE-PA has a market cap of 5.2M. Regarding current trading prices, MCTA is priced at $29.36 on the NASDAQ, while RHE-PA trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCTA currently has a P/E ratio of 419.36, whereas RHE-PA's P/E ratio is -0.09. In terms of profitability, MCTA's ROE is -2.33%, compared to RHE-PA's ROE of +2.11%. Regarding short-term risk, MCTA is less volatile compared to RHE-PA. This indicates lower risk in terms of short-term price fluctuations for MCTA.Check RHE-PA's competition here
20/20 Biolabs Inc. (NASDAQ: AIDX)
MCTA vs AIDX Comparison July 2026
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCTA stands at 445.6M. In comparison, AIDX has a market cap of 2.5M. Regarding current trading prices, MCTA is priced at $29.36 on the NASDAQ, while AIDX trades at $0.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCTA currently has a P/E ratio of 419.36, whereas AIDX's P/E ratio is -0.85. In terms of profitability, MCTA's ROE is -2.33%, compared to AIDX's ROE of +0.79%. Regarding short-term risk, MCTA is less volatile compared to AIDX. This indicates lower risk in terms of short-term price fluctuations for MCTA.Check AIDX's competition here
IMAC Holdings, Inc. (NASDAQ: IMACW)
MCTA vs IMACW Comparison July 2026
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCTA stands at 445.6M. In comparison, IMACW has a market cap of 1.7M. Regarding current trading prices, MCTA is priced at $29.36 on the NASDAQ, while IMACW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCTA currently has a P/E ratio of 419.36, whereas IMACW's P/E ratio is N/A. In terms of profitability, MCTA's ROE is -2.33%, compared to IMACW's ROE of +0.73%. Regarding short-term risk, MCTA is less volatile compared to IMACW. This indicates lower risk in terms of short-term price fluctuations for MCTA.Check IMACW's competition here
Nakamoto Inc. (NASDAQ: NAKAW)
MCTA vs NAKAW Comparison July 2026
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCTA stands at 445.6M. In comparison, NAKAW has a market cap of 1.5M. Regarding current trading prices, MCTA is priced at $29.36 on the NASDAQ, while NAKAW trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCTA currently has a P/E ratio of 419.36, whereas NAKAW's P/E ratio is -0.53. In terms of profitability, MCTA's ROE is -2.33%, compared to NAKAW's ROE of -0.85%. Regarding short-term risk, MCTA is similarly volatile compared to NAKAW. This indicates similar risk in terms of short-term price fluctuations for MCTA.Check NAKAW's competition here
Concord Medical Services Holdings Limited (NYSE: CCM)
MCTA vs CCM Comparison July 2026
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCTA stands at 445.6M. In comparison, CCM has a market cap of 653.1K. Regarding current trading prices, MCTA is priced at $29.36 on the NASDAQ, while CCM trades at $4.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCTA currently has a P/E ratio of 419.36, whereas CCM's P/E ratio is -0.30. In terms of profitability, MCTA's ROE is -2.33%, compared to CCM's ROE of +0.06%. Regarding short-term risk, MCTA is less volatile compared to CCM. This indicates lower risk in terms of short-term price fluctuations for MCTA.Check CCM's competition here
NewGenIvf Group Limited (NASDAQ: NIVF)
MCTA vs NIVF Comparison July 2026
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCTA stands at 445.6M. In comparison, NIVF has a market cap of 199K. Regarding current trading prices, MCTA is priced at $29.36 on the NASDAQ, while NIVF trades at $1.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCTA currently has a P/E ratio of 419.36, whereas NIVF's P/E ratio is 0.52. In terms of profitability, MCTA's ROE is -2.33%, compared to NIVF's ROE of +0.33%. Regarding short-term risk, MCTA is less volatile compared to NIVF. This indicates lower risk in terms of short-term price fluctuations for MCTA.Check NIVF's competition here
NewGenIvf Group Limited (NASDAQ: NIVFW)
MCTA vs NIVFW Comparison July 2026
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCTA stands at 445.6M. In comparison, NIVFW has a market cap of 50K. Regarding current trading prices, MCTA is priced at $29.36 on the NASDAQ, while NIVFW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCTA currently has a P/E ratio of 419.36, whereas NIVFW's P/E ratio is -0.01. In terms of profitability, MCTA's ROE is -2.33%, compared to NIVFW's ROE of +0.33%. Regarding short-term risk, MCTA is less volatile compared to NIVFW. This indicates lower risk in terms of short-term price fluctuations for MCTA.Check NIVFW's competition here
Mobile-health Network Solutions Class A Ordinary Shares (NASDAQ: MNDR)
MCTA vs MNDR Comparison July 2026
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCTA stands at 445.6M. In comparison, MNDR has a market cap of 43.8K. Regarding current trading prices, MCTA is priced at $29.36 on the NASDAQ, while MNDR trades at $1.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCTA currently has a P/E ratio of 419.36, whereas MNDR's P/E ratio is -0.04. In terms of profitability, MCTA's ROE is -2.33%, compared to MNDR's ROE of -0.46%. Regarding short-term risk, MCTA is less volatile compared to MNDR. This indicates lower risk in terms of short-term price fluctuations for MCTA.Check MNDR's competition here
Talkspace, Inc. (NASDAQ: TALKW)
MCTA vs TALKW Comparison July 2026
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCTA stands at 445.6M. In comparison, TALKW has a market cap of 33.5K. Regarding current trading prices, MCTA is priced at $29.36 on the NASDAQ, while TALKW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCTA currently has a P/E ratio of 419.36, whereas TALKW's P/E ratio is 0.00. In terms of profitability, MCTA's ROE is -2.33%, compared to TALKW's ROE of +0.01%. Regarding short-term risk, MCTA is less volatile compared to TALKW. This indicates lower risk in terms of short-term price fluctuations for MCTA.Check TALKW's competition here
SOC Telemed, Inc. (NASDAQ: TLMDW)
MCTA vs TLMDW Comparison July 2026
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCTA stands at 445.6M. In comparison, TLMDW has a market cap of 0. Regarding current trading prices, MCTA is priced at $29.36 on the NASDAQ, while TLMDW trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCTA currently has a P/E ratio of 419.36, whereas TLMDW's P/E ratio is N/A. In terms of profitability, MCTA's ROE is -2.33%, compared to TLMDW's ROE of -0.46%. Regarding short-term risk, MCTA is less volatile compared to TLMDW. This indicates lower risk in terms of short-term price fluctuations for MCTA.Check TLMDW's competition here
Hanger, Inc. (NYSE: HNGR)
MCTA vs HNGR Comparison July 2026
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCTA stands at 445.6M. In comparison, HNGR has a market cap of 0. Regarding current trading prices, MCTA is priced at $29.36 on the NASDAQ, while HNGR trades at $18.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCTA currently has a P/E ratio of 419.36, whereas HNGR's P/E ratio is 19.71. In terms of profitability, MCTA's ROE is -2.33%, compared to HNGR's ROE of +0.52%. Regarding short-term risk, MCTA is less volatile compared to HNGR. This indicates lower risk in terms of short-term price fluctuations for MCTA.Check HNGR's competition here
ATI Physical Therapy, Inc. (NYSE: ATIP-WT)
MCTA vs ATIP-WT Comparison July 2026
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCTA stands at 445.6M. In comparison, ATIP-WT has a market cap of 0. Regarding current trading prices, MCTA is priced at $29.36 on the NASDAQ, while ATIP-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCTA currently has a P/E ratio of 419.36, whereas ATIP-WT's P/E ratio is N/A. In terms of profitability, MCTA's ROE is -2.33%, compared to ATIP-WT's ROE of +2.05%. Regarding short-term risk, MCTA is less volatile compared to ATIP-WT. This indicates lower risk in terms of short-term price fluctuations for MCTA.Check ATIP-WT's competition here
Skylight Health Group Inc. (NASDAQ: SLHG)
MCTA vs SLHG Comparison July 2026
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCTA stands at 445.6M. In comparison, SLHG has a market cap of 0. Regarding current trading prices, MCTA is priced at $29.36 on the NASDAQ, while SLHG trades at $0.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCTA currently has a P/E ratio of 419.36, whereas SLHG's P/E ratio is -1.48. In terms of profitability, MCTA's ROE is -2.33%, compared to SLHG's ROE of N/A. Regarding short-term risk, MCTA is less volatile compared to SLHG. This indicates lower risk in terms of short-term price fluctuations for MCTA.Check SLHG's competition here
Almost Family Inc. (NASDAQ: AFAM)
MCTA vs AFAM Comparison July 2026
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCTA stands at 445.6M. In comparison, AFAM has a market cap of 0. Regarding current trading prices, MCTA is priced at $29.36 on the NASDAQ, while AFAM trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCTA currently has a P/E ratio of 419.36, whereas AFAM's P/E ratio is N/A. In terms of profitability, MCTA's ROE is -2.33%, compared to AFAM's ROE of +0.06%. Regarding short-term risk, MCTA is less volatile compared to AFAM. This indicates lower risk in terms of short-term price fluctuations for MCTA.Check AFAM's competition here
SOC Telemed, Inc. (NASDAQ: TLMD)
MCTA vs TLMD Comparison July 2026
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCTA stands at 445.6M. In comparison, TLMD has a market cap of 0. Regarding current trading prices, MCTA is priced at $29.36 on the NASDAQ, while TLMD trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCTA currently has a P/E ratio of 419.36, whereas TLMD's P/E ratio is -1.60. In terms of profitability, MCTA's ROE is -2.33%, compared to TLMD's ROE of -0.46%. Regarding short-term risk, MCTA is less volatile compared to TLMD. This indicates lower risk in terms of short-term price fluctuations for MCTA.Check TLMD's competition here
Skylight Health Group Inc. (NASDAQ: SLHGP)
MCTA vs SLHGP Comparison July 2026
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCTA stands at 445.6M. In comparison, SLHGP has a market cap of 0. Regarding current trading prices, MCTA is priced at $29.36 on the NASDAQ, while SLHGP trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCTA currently has a P/E ratio of 419.36, whereas SLHGP's P/E ratio is -30.38. In terms of profitability, MCTA's ROE is -2.33%, compared to SLHGP's ROE of -0.48%. Regarding short-term risk, MCTA is similarly volatile compared to SLHGP. This indicates similar risk in terms of short-term price fluctuations for MCTA.Check SLHGP's competition here
Tivity Health, Inc. (NASDAQ: TVTY)
MCTA vs TVTY Comparison July 2026
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCTA stands at 445.6M. In comparison, TVTY has a market cap of 0. Regarding current trading prices, MCTA is priced at $29.36 on the NASDAQ, while TVTY trades at $32.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCTA currently has a P/E ratio of 419.36, whereas TVTY's P/E ratio is 19.06. In terms of profitability, MCTA's ROE is -2.33%, compared to TVTY's ROE of +1.75%. Regarding short-term risk, MCTA is less volatile compared to TVTY. This indicates lower risk in terms of short-term price fluctuations for MCTA.Check TVTY's competition here
Kindred Healthcare, Inc. (NYSE: KND)
MCTA vs KND Comparison July 2026
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCTA stands at 445.6M. In comparison, KND has a market cap of 0. Regarding current trading prices, MCTA is priced at $29.36 on the NASDAQ, while KND trades at $9.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCTA currently has a P/E ratio of 419.36, whereas KND's P/E ratio is -1.14. In terms of profitability, MCTA's ROE is -2.33%, compared to KND's ROE of -0.53%. Regarding short-term risk, MCTA is less volatile compared to KND. This indicates lower risk in terms of short-term price fluctuations for MCTA.Check KND's competition here
Diversicare Healthcare Services, Inc. (NASDAQ: DVCR)
MCTA vs DVCR Comparison July 2026
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCTA stands at 445.6M. In comparison, DVCR has a market cap of 0. Regarding current trading prices, MCTA is priced at $29.36 on the NASDAQ, while DVCR trades at $10.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCTA currently has a P/E ratio of 419.36, whereas DVCR's P/E ratio is 28.34. In terms of profitability, MCTA's ROE is -2.33%, compared to DVCR's ROE of -0.15%. Regarding short-term risk, MCTA is less volatile compared to DVCR. This indicates lower risk in terms of short-term price fluctuations for MCTA.Check DVCR's competition here
New Frontier Health Corporation (NYSE: NFH)
MCTA vs NFH Comparison July 2026
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCTA stands at 445.6M. In comparison, NFH has a market cap of 0. Regarding current trading prices, MCTA is priced at $29.36 on the NASDAQ, while NFH trades at $11.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCTA currently has a P/E ratio of 419.36, whereas NFH's P/E ratio is -19.75. In terms of profitability, MCTA's ROE is -2.33%, compared to NFH's ROE of -0.06%. Regarding short-term risk, MCTA is less volatile compared to NFH. This indicates lower risk in terms of short-term price fluctuations for MCTA.Check NFH's competition here
DocGo Inc. (NASDAQ: DCGOW)
MCTA vs DCGOW Comparison July 2026
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCTA stands at 445.6M. In comparison, DCGOW has a market cap of 0. Regarding current trading prices, MCTA is priced at $29.36 on the NASDAQ, while DCGOW trades at $1.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCTA currently has a P/E ratio of 419.36, whereas DCGOW's P/E ratio is N/A. In terms of profitability, MCTA's ROE is -2.33%, compared to DCGOW's ROE of -0.89%. Regarding short-term risk, MCTA is less volatile compared to DCGOW. This indicates lower risk in terms of short-term price fluctuations for MCTA.Check DCGOW's competition here